IP Library Patent Application 11810309
Patent Application
App. No. 11/810,309

Compositions and methods for removal of DNA from a sample

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/810,309
Abstract

The present invention provides compositions and methods for digesting DNA. In particular, the present invention provides enzymes mixtures that provide enhanced DNA digestion and methods of using the enzyme mixtures to eliminate or reduce undesired DNA molecules from a sample of interest.

Claims (40)

1 . A composition comprising a purified type I DNase and a purified complementary DNase enzyme.

2 . The composition of claim 1 , wherein said type I DNase and said complementary DNase enzyme are provided together in a buffer.

3 . The composition of claim 1 , wherein said type I DNase and said complementary DNase enzyme are provided together in a reaction mixture.

4 . The composition of claim 1 , further comprising RNA molecules.

5 . The composition of claim 1 , further comprising cultured cells.

6 . The composition of claim 1 , further comprising a restriction enzyme.

7 . The composition of claim 1 , wherein said type I DNase is human, bovine, or porcine DNase I.

8 . The composition of claim 1 , wherein said type I DNase is recombinant type I DNase.

9 . The composition of claim 1 , wherein said complementary DNase enzyme is an exonuclease I enzyme.

10 . A kit comprising a purified type I DNase and a purified complementary DNase enzyme.

11 . The kit of claim 10 , wherein said type I DNase and said complementary DNase enzyme are provided at at least 5-fold concentration excess of a reaction concentration.

12 . The kit of claim 10 , the kit further comprises a reaction buffer.

13 . The kit of claim 10 , wherein said type I DNase and said complementary DNase enzyme are provided together in the same vessel.

14 . The kit of claim 10 , further comprising an RNA molecule as a control.

15 . The kit of claim 10 , further comprising a DNA molecule as a control.

16 . The kit of claim 10 , further comprising a reverse transcriptase.

17 . The kit of claim 10 , further comprising a DNA polymerase.

18 . The kit of claim 10 , further comprising oligonucleotide primers.

19 . The kit of claim 10 , further comprising an RNA polymerase.

20 . The kit of claim 10 , further comprising an agent that inactivates type I DNase.

21 . The kit of claim 10 , wherein said type I DNase and said complementary DNase are contained in separate vessels.

22 . The kit of claim 10 , wherein said type I DNase is a human, bovine or porcine DNase I.

23 . The kit of claim 10 , wherein said type I DNase is recombinant type I DNase.

24 . The kit of claim 10 , wherein said complementary DNase enzyme is an exonuclease I enzyme.

25 . A method of digesting DNA in a sample, comprising: treating a sample suspected of comprising DNA with an enzyme mixture comprising a purified type I DNase and a purified complementary DNase enzyme.

26 . The method of claim 25 , wherein said type I DNase and said complementary DNase enzyme are provided together in a buffer.

27 . The method of claim 25 , wherein said sample comprises RNA molecules.

28 . The method of claim 27 , further comprising the step of isolating said RNA molecules.

29 . The method of claim 27 , further comprising the step of treating the sample with a reverse transcriptase.

30 . The method of claim 29 , further comprising the step of treating the sample with a DNA polymerase.

31 . The method of claim 27 , further comprising the step of generating cDNA from said RNA.

32 . The method of claim 31 , further comprising the step of amplifying said cDNA using a polymerase chain reaction.

33 . The method of claim 32 , further comprising synthesizing RNA from said cDNA using an RNA amplification reaction.

34 . The method of claim 25 , wherein said sample comprises RNA molecules generated by an in vitro transcription reaction.

35 . The method of claim 25 , wherein said sample comprises cultured cells.

36 . The method of claim 25 , wherein said type I DNase is a DNase I enzyme.

37 . The method of claim 25 , wherein said complementary DNase enzyme is an exonuclease I enzyme.

38 . A method for digesting DNA in mucus, comprising: exposing mucus suspected of comprising DNA to a purified type I DNase and a purified complementary DNase enzyme.

39 . The method of claim 38 , wherein said type I DNase is a DNase I enzyme.

40 . The method of claim 38 , wherein said complementary DNase enzyme is an exonuclease I enzyme.

Assignments (2)
MERGER Recorded Dec 3, 2020
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ILLUMINA, INC.
Reel/Frame 054585/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2007
From: JENDRISAK, JEROME; GRUNENWALD, HAIYING L.
To: EPICENTRE TECHNOLOGIES
Reel/Frame 019831/0550 →